Laura Downing
Obstetrics & Gynecology · Austin, TXNPI 1053677716
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,600 of the $13,393 with a category attached, or 71.7%. Surgenex LLC accounts for 71.7% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $9,954, more than ten times the $449 reported in 2019. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $61.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Surgenex LLC$10K
- AbbVie$768
- Exeltis, USA Inc.$494
- Mayne Pharma Commercial LLC$406
- Therapeuticsmd, Inc.$300
- Astellas Pharma US Inc$274
- plus $2K from 22 others
Across 126 payments — averaging $3573.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$212K
- GSK$97K
- Dexcom, Inc.$56K
- Organon$44K
- Sumitomo Pharma America, Inc.$32K
- Astellas Pharma Global Development$10K
What the payments were for
- Speaking & faculty fees$9,60072%
- Food & beverage$3,69328%
- Education$1001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Surgenex LLC | 4 | $9,600 |
| AbbVie(2 entities) | 53 | $768 |
| Exeltis, USA Inc. | 36 | $494 |
| Mayne Pharma Commercial LLC | 16 | $406 |
| Therapeuticsmd, Inc. | 23 | $300 |
| Astellas Pharma US Inc | 10 | $274 |
| Coopersurgical, Inc. | 8 | $238 |
| Hologic Sales And Service, LLC | 10 | $165 |
| Biogen | 7 | $158 |
| Evofem Biosciences, Inc. | 8 | $154 |
| Pacira Pharmaceuticals Incorporated | 1 | $118 |
| Organon | 5 | $110 |
| Agile Therapeutics, Inc. | 6 | $93 |
| Avion Pharmaceuticals | 7 | $92 |
| Myovant Sciences Inc. | 3 | $66 |
| Innovation Technologies Inc | 1 | $58 |
| Millicent US Inc | 3 | $45 |
| Lupin Inc. | 3 | $42 |
| Mission Pharmacal Company | 2 | $40 |
| Bayer | 2 | $38 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Shield Therapeutics Inc | 1 | $19 |
| Mylan Pharmaceuticals Inc. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Davol Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Duchesnay USA Incorporated | 1 | $13 |
| Minerva Surgical, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SurGraft$9,600
- ArdeoGraft$9,600
- PelloGraft$9,600
- RenoGraft$9,600
- VitoGraft$9,600
- EXPAREL$118
How this compares
$13,393 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.
Other obstetrics & gynecology in Austin
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Renu ChalasaniAustin$156K
- Sharyl Brasher-GilesAustin$42K
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.